MedTrace Logo

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema

NCT03825263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-31

No results posted yet for this study

Summary

The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression, specifically the LymphAssist (Huntleigh Healthcare), represents an innovative treatment for this condition but the efficacy of this device needs to be investigated via robust clinical research.

Conditions

  • Lymphoedema

Interventions

DEVICE

Intermittent Pressure Compression

The intervention group use the IPC device for 6 months. Clinic assessment were completed at the beginning and at 3 and 6 months. Participants in the intervention group were invited to use the IPC device twice a day every day during this period.

Sponsors & Collaborators

  • Cwm Taf University Health Board (NHS)

    collaborator OTHER_GOV

  • University of South Wales

    lead OTHER

Principal Investigators

  • Mark Williams, Phd · University of South Wales

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-01-17
Completion
2018-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03825263 on ClinicalTrials.gov